Kyverna Therapeutics, Inc. - KYTX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | — | A | A | 20,582.0 | 0.0 | 0.0 | 20,582.0 | View | |
| May 29, 2026 | — | A | A | 5,093.0 | 0.0 | 0.0 | 21,727.0 | View | |
| May 29, 2026 | — | A | A | 20,582.0 | 0.0 | 0.0 | 20,582.0 | View | |
| May 29, 2026 | — | A | A | 5,093.0 | 0.0 | 0.0 | 21,727.0 | View | |
| May 29, 2026 | — | A | A | 20,582.0 | 0.0 | 0.0 | 20,582.0 | View | |
| May 29, 2026 | — | A | A | 5,093.0 | 0.0 | 0.0 | 21,727.0 | View | |
| May 29, 2026 | Executive Chairperson | F | D | 4,194.0 | 8.59 | 36,026.46 | 66,741.0 | View | |
| May 29, 2026 | — | A | A | 20,582.0 | 0.0 | 0.0 | 20,582.0 | View | |
| May 29, 2026 | — | A | A | 5,093.0 | 0.0 | 0.0 | 21,727.0 | View | |
| May 20, 2026 | Chief Financial Officer | A | A | 325,000.0 | 0.0 | 0.0 | 325,000.0 | View | |
| May 06, 2026 | Chief Commercial Officer | A | A | 300,000.0 | 0.0 | 0.0 | 300,000.0 | View |